Clinical Trial Update: Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers [Phase 1]

View source ↗

Summary

A Phase 1 trial examining whether pretreatment with metformin affects colorectal cancer stem cells and related pharmacodynamic markers has been terminated. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Tufts Medical Center | Conditions: Colon Cancer | Phase 1 | Status: TERMINATED